Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
Do you have any clinical experience regarding the administration of B cell depleting therapies in MS patients with splenectomy?
Related Questions
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
What biomarkers best predict the response to B-cell depleting therapies in MS?
What are red flags in an evaluation for possible multiple sclerosis that should prompt workup for genetic/inherited conditions?
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
How do you decide on long term immunosuppression therapy for Susac Syndrome?
When do you switch to a different DMT in multiple sclerosis patients planning for pregnancy?
When do you consider disease modifying therapy in radiographically isolated syndrome?
